Effect of dihydroergotoxine, a cerebral vasodilator, on cognitive deficits induced by prenatal undernutrition and environmental impoverishment in young rats.
The study was conducted on 64 Charles Foster strain albino rats, which were equally distributed into 8 evenly matched groups, following a 2 x 2 x 2 factorial design, by varying three independent factors at two levels: nutrition--normal and undernutrition; environment--enrichment and impoverishment, and drug treatment--vehicle and dihydroergotoxine (3 mg/kg, i.p.). Prenatal undernutrition was induced by restricting the mother's food intake. The environmental enrichment/impoverishment and the vehicle/dihydroergotoxine treatments were given during the postweaning period of the pups. The rats were subjected to original and subsequent reversal brightness discrimination learning tests in a single unit T-maze at 8-9 weeks of age. Thereafter, the animals were tested for passive avoidance learning. The results indicate that undernutrition caused significant original and reversal discrimination learning, deficits whereas environmental deprivation attenuated only the original discrimination learning performance. Dihydroergotoxine treatment facilitated the learning performance of rats in both the original and reversal learning tests. Nutritional, environmental and dihydroergotoxine treatments had no effect on the retention of the passive avoidance learning, both at 24 hr and 1 week intervals. Dihydroergotoxine treatment attenuated the learning deficits induced by prenatal undernutrition. The results indicate that dihydroergotoxine is not likely to be useful in cognitive deficits, induced by malnutrition, though it facilitated learning acquisition, since it had no effect on retention.
Jaiswal
A K
AK
Department of Pharmacology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Upadhyay
S N
SN
Bhattacharya
S K
SK
D000818:Animals; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology; D004088:Dihydroergotoxine / Q000627:therapeutic use*; D005260:Female; D007858:Learning / Q000187:drug effects*; D008297:Male; D009748:Nutrition Disorders / Q000150:complications*; D051381:Rats; D014665:Vasodilator Agents / Q000627:therapeutic use*
D014665:Vasodilator Agents; D004088:Dihydroergotoxine